An additional analysis of HDAC1–3 expression for hormone receptor–based characterization of breast cancer also revealed significant alterations in expression of HDAC 1 and 2, but not HDAC3 (Fig. 6c) across various subtypes. This evidence concerns the gene NR4A1 and breast cancer.